The spectrum of genetic alterations in anaplastic gliomas: and anaplastic oligodendrogliomas

Ryzhova M.V.

FGBU "NII neĭrokhirurgii im. akad. N.N. Burdenko" RAMN, Moskva

Shaykhaev E.G.

Russian Scientific Center of Roentgen Radiology, Moscow, Russia, 117997

Kazarova M.V.

Russian Scientific Center of Roentgen Radiology, Moscow, Russia, 117997

Telysheva E.N.

Russian Scientific Center of Roentgen Radiology, Moscow, Russia, 117997

Shishkina L.V.

Burdenko Neurosurgery Institute, Moscow, Russia

Shibaeva I.V.

Burdenko Neurosurgical Institute, Moscow, Russia, 125047

Shugay S.V.

Burdenko Neurosurgical Institute, Moscow, Russia, 125047

Voronina E.I.

Regional Center of High Medical Technologies, Novosibirsk, Russia;
Novosibirsk State Medical University, Novosibirsk, Russia

Snigireva G.P.

Russian Scientific Center of Roentgen Radiology, Moscow, Russia, 117997

The spectrum of genetic alterations in anaplastic gliomas: and anaplastic oligodendrogliomas

Authors:

Ryzhova M.V., Shaykhaev E.G., Kazarova M.V., Telysheva E.N., Shishkina L.V., Shibaeva I.V., Shugay S.V., Voronina E.I., Snigireva G.P.

More about the authors

Journal: Burdenko's Journal of Neurosurgery. 2017;81(6): 26‑31

DOI: 10.17116/neiro201781626-31

Downloaded: 39

To cite this article:

Ryzhova MV, Shaykhaev EG, Kazarova MV, et al. . The spectrum of genetic alterations in anaplastic gliomas: and anaplastic oligodendrogliomas. Burdenko's Journal of Neurosurgery. 2017;81(6):26‑31. (In Russ., In Engl.)
https://doi.org/10.17116/neiro201781626-31

Подписка 2025-2 (Burdenko's Journal of Neurosurgery)

Close metadata

Recommended articles:

Molecularly targeted therapy for biliary cancer. P.A. Herzen Journal of Oncology. 2024;(3):34-39

Endometrial adenocarcinoma with mutations in POLE, TP53 genes and microsatellite instability. Russian Journal of Archive of Pathology. 2024;(6):58-62

The work explores the molecular genetic features of anaplastic astrocytomas and oligodendrogliomas in a series of 43 cases. The mutational status was studied using domestic chemicals and reagent kits. We revealed clear genetic differences between astrocytic and oligodendroglial tumors and proposed an algorithm to study diagnostic and prognostic markers.

Keywords:

gliomas

ATRX

IDH1

TP53

MGMT

1p19q

Authors:

Ryzhova M.V.

FGBU "NII neĭrokhirurgii im. akad. N.N. Burdenko" RAMN, Moskva

Shaykhaev E.G.

Russian Scientific Center of Roentgen Radiology, Moscow, Russia, 117997

Kazarova M.V.

Russian Scientific Center of Roentgen Radiology, Moscow, Russia, 117997

Telysheva E.N.

Russian Scientific Center of Roentgen Radiology, Moscow, Russia, 117997

Shishkina L.V.

Burdenko Neurosurgery Institute, Moscow, Russia

Shibaeva I.V.

Burdenko Neurosurgical Institute, Moscow, Russia, 125047

Shugay S.V.

Burdenko Neurosurgical Institute, Moscow, Russia, 125047

Voronina E.I.

Regional Center of High Medical Technologies, Novosibirsk, Russia;
Novosibirsk State Medical University, Novosibirsk, Russia

Snigireva G.P.

Russian Scientific Center of Roentgen Radiology, Moscow, Russia, 117997

List of references:

Buczkowicz P, Bartels U, Bouffet E, Becher O, Hawkins C. Histopathological spectrum of paediatric diffuse intrinsic pontine glioma: diagnostic and therapeutic implications. Acta Neuropathol. 2014 Oct;128(4):573-581. https://doi.org/10.1007/s00401-014-1319-6
Louis DN, Ohgaki H, Wiestler OD, Cavenee WK. (Eds.): WHO classification of tumours of the central nervous system (revised 4^th ed.). IARC: Lyon. 2016.
Sahm F, Reuss D, Koelsche C, Capper D, Schittenhelm J, Heim S, Jones DT, Pfister SM, Herold-Mende C, Wick W, Mueller W, Hartmann C, Paulus W, von Deimling A. Farewell to oligoastrocytoma: in situ molecular genetics favor classification as either oligodendroglioma or astrocytoma. Acta Neuropathol. 2014 Oct;128(4):551-559. https://doi.org/10.1007/s00401-014-1326-7
Hong CS, Hsieh JK, Edwards NA, Ray-Chaudhury A, Zaghloul KA. IDH mutations may not preclude distant, trans-tentorial spread in gliomas: a case report and review of the literature. World J Surg Oncol. 2016 Feb 24;14:53. https://doi.org/10.1186/s12957-016-0814-8
Haberler C, Wöhrer A. Clinical Neuropathology practice news 2-2014: ATRX, a new candidate biomarker in gliomas. Clin Neuropathol. 2014 Mar-Apr;33(2):108-111.
Ikemura M, Shibahara J, Mukasa A, Takayanagi S, Aihara K, Saito N, Aburatani H, Fukayama M. Utility of ATRX immunohistochemistry in diagnosis of adult diffuse gliomas. Histopathology. 2016 Aug;69(2):260-267. https://doi.org/10.1111/his.12927
Leeper HE, Caron AA, Decker PA, Jenkins RB, Lachance DH, Giannini C. IDH mutation, 1p19q codeletion and ATRX loss in WHO grade II gliomas. Oncotarget. 2015 Oct 6;6(30):30295-30305. https://doi.org/10.18632/oncotarget.4497
Qi S, Yu L, Li H, Ou Y, Qiu X, Ding Y, Han H, Zhang X. Isocitrate dehydrogenase mutation is associated with tumor location and magnetic resonance imaging characteristics in astrocytic neoplasms. Oncol Lett. 2014 Jun;7(6):1895-1902.
Shao LW, Pan Y, Qi XL, Li YX, Ma XL, Yi WN, Zhang J, Zhong YF, Chang Q. ATRX loss in adult supratentorial diffuse astrocytomas correlates with p53 over expression and IDH1 mutation and predicts better outcome in p53 accumulated patients. Histol Histopathol. 2016 Jan;31(1):103-114. https://doi.org/10.14670/HH-11-664
Zacher A, Kaulich K, Stepanow S, Wolter M, Köhrer K, Felsberg J, Malzkorn B, Reifenberger G. Molecular diagnostics of gliomas using next generation sequencing of a glioma-tailored gene panel. Brain Pathol. 2016 Feb 25. https://doi.org/10.1111/bpa.12367
Cai J, Zhu P, Zhang C, Li Q, Wang Z, Li G, Wang G, Yang P, Li J, Han B, Jiang C, Sun Y, Jiang T. Detection of ATRX and IDH1-R132H immunohistochemistry in the progression of 211 paired gliomas. Oncotarget. 2016 Mar 29;7(13):16384-16395. https://doi.org/10.18632/oncotarget.7650
Ebrahimi A, Skardelly M, Bonzheim I, Ott I, Mühleisen H, Eckert F, Tabatabai G, Schittenhelm J. ATRX immunostaining predicts IDH and H3F3A status in gliomas. Acta Neuropathol Commun. 2016 Jun 16;4(1):60. https://doi.org/10.1186/s40478-016-0331-6
Foote MB, Papadopoulos N, Diaz LAJr. Genetic classification of gliomas: refining histopathology. Cancer Cell. 2015 Jul 13;28(1):9-11. https://doi.org/10.1016/j.ccell.2015.06.014
Takano S, Ishikawa E, Sakamoto N, Matsuda M, Akutsu H, Noguchi M, Kato Y, Yamamoto T, Matsumura A. Immunohistochemistry on IDH 1/2, ATRX, p53 and Ki-67 substitute molecular genetic testing and predict patient prognosis in grade III adult diffuse gliomas. Brain Tumor Pathol. 2016 Apr;33(2):107-116. https://doi.org/10.1007/s10014-016-0260-x
Tanboon J, Williams EA, Louis DN. The Diagnostic use of immunohistochemical surrogates for signature molecular genetic alterations in gliomas. J Neuropathol Exp Neurol. 2016 Jan;75(1):4-18.
Ryzhova MV, Shishkina LV, Zheludkova OG, Golanov AV, Gorelyshev SK, Pitskhelauri DI, Bekiashev AKh, Kobiakov GL, Absaliamova OV, Sycheva RV, Korshunov AG. Comparative characteristics of genetic aberrations in glioblastomas in children and adults]. Zh Vopr Neirokhir Im N N Burdenko. 2014;78(2):3-11; discussion 11. (In Russ.)
Weller M, Pfister SM, Wick W, Hegi ME, Reifenberger G, Stupp R. Molecular neuro-oncology in clinical practice: a new horizon. Lancet Oncol. 2013 Aug;14(9):e370-e379. https://doi.org/10.1016/S1470-2045(13)70168-2
Brandner S, von Deimling A. Diagnostic, prognostic and predictive relevance of molecular markers in gliomas. Neuropathol Appl Neurobiol. 2015 Oct;41(6):694-720. https://doi.org/10.1111/nan.12246
Korshunov A, Capper D, Reuss D, Schrimpf D, Ryzhova M, Hovestadt V, Sturm D, Meyer J, Jones C, Zheludkova O, Kumirova E, Golanov A, Kool M, Schüller U, Mittelbronn M, Hasselblatt M, Schittenhelm J, Reifenberger G, Herold-Mende C, Lichter P, von Deimling A, Pfister SM, Jones DT. Histologically distinct neuroepithelial tumors with histone 3 G34 mutation are molecularly similar and comprise a single nosologic entity. Acta Neuropathol. 2016 Jan;131(1):137-146.
Weller M, van den Bent M, Hopkins K, Tonn JC, Stupp R, Falini A, Cohen-Jonathan-Moyal E, Frappaz D, Henriksson R, Balana C, Chinot O, Ram Z, Reifenberger G, Soffietti R, Wick W; European Association for Neuro-Oncology (EANO) Task Force on Malignant Glioma. EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma. Lancet Oncol. 2014 Aug;15(9):e395-403. https://doi.org/10.1016/S1470-2045(14)70011-7
Cahill DP, Louis DN, Cairncross JG. Molecular background of oligodendroglioma: 1p/19q, IDH, TERT, CIC and FUBP1. CNS Oncol. 2015;4(5):287-294. https://doi.org/10.2217/cns.15.32
Masui K, Mischel PS, Reifenberger G. Molecular classification of gliomas. Handb Clin Neurol. 2016;134:97-120. https://doi.org/10.1016/B978-0-12-802997-8.00006-2
Siegal T. Clinical relevance of prognostic and predictive molecular markers in gliomas. Adv Tech Stand Neurosurg. 2016;(43):91-108. https://doi.org/10.1007/978-3-319-21359-0_4
Cancer Genome Atlas Research Network, Brat DJ, Verhaak RG, Aldape KD, Yung WK, Salama SR, Cooper LA, Rheinbay E, Miller CR, Vitucci M, Morozova O, Robertson AG, Noushmehr H, Laird PW, Cherniack AD, Akbani R, Huse JT, Ciriello G, Poisson LM, Barnholtz-Sloan JS, Berger MS, Brennan C, Colen RR, Colman H, Flanders AE, Giannini C, Grifford M, Iavarone A, Jain R, Joseph I, Kim J, Kasaian K, Mikkelsen T, Murray BA, O’Neill BP, Pachter L, Parsons DW, Sougnez C, Sulman EP, Vandenberg SR, Van Meir EG, von Deimling A, Zhang H, Crain D, Lau K, Mallery D, Morris S, Paulauskis J, Penny R, Shelton T, Sherman M, Yena P, Black A, Bowen J, Dicostanzo K, Gastier-Foster J, Leraas KM, Lichtenberg TM, Pierson CR, Ramirez NC, Taylor C, Weaver S, Wise L, Zmuda E, Davidsen T, Demchok JA, Eley G, Ferguson ML, Hutter CM, Mills Shaw KR, Ozenberger BA, Sheth M, Sofia HJ, Tarnuzzer R, Wang Z, Yang L, Zenklusen JC, Ayala B, Baboud J, Chudamani S, Jensen MA, Liu J, Pihl T, Raman R, Wan Y, Wu Y, Ally A, Auman JT, Balasundaram M, Balu S, Baylin SB, Beroukhim R, Bootwalla MS, Bowlby R, Bristow CA, Brooks D, Butterfield Y, Carlsen R, Carter S, Chin L, Chu A, Chuah E, Cibulskis K, Clarke A, Coetzee SG, Dhalla N, Fennell T, Fisher S, Gabriel S, Getz G, Gibbs R, Guin R, Hadjipanayis A, Hayes DN, Hinoue T, Hoadley K, Holt RA, Hoyle AP, Jefferys SR, Jones S, Jones CD, Kucherlapati R, Lai PH, Lander E, Lee S, Lichtenstein L, Ma Y, Maglinte DT, Mahadeshwar HS, Marra MA, Mayo M, Meng S, Meyerson ML, Mieczkowski PA, Moore RA, Mose LE, Mungall AJ, Pantazi A, Parfenov M, Park PJ, Parker JS, Perou CM, Protopopov A, Ren X, Roach J, Sabedot TS, Schein J, Schumacher SE, Seidman JG, Seth S, Shen H, Simons JV, Sipahimalani P, Soloway MG, Song X, Sun H, Tabak B, Tam A, Tan D, Tang J, Thiessen N, Triche T Jr, Van Den Berg DJ, Veluvolu U, Waring S, Weisenberger DJ, Wilkerson MD, Wong T, Wu J, Xi L, Xu AW, Yang L, Zack TI, Zhang J, Aksoy BA, Arachchi H, Benz C, Bernard B, Carlin D, Cho J, DiCara D, Frazer S, Fuller GN, Gao J, Gehlenborg N, Haussler D, Heiman DI, Iype L, Jacobsen A, Ju Z, Katzman S, Kim H, Knijnenburg T, Kreisberg RB, Lawrence MS, Lee W, Leinonen K, Lin P, Ling S, Liu W, Liu Y, Liu Y, Lu Y, Mills G, Ng S, Noble MS, Paull E, Rao A, Reynolds S, Saksena G, Sanborn Z, Sander C, Schultz N, Senbabaoglu Y, Shen R, Shmulevich I, Sinha R, Stuart J, Sumer SO, Sun Y, Tasman N, Taylor BS, Voet D, Weinhold N, Weinstein JN, Yang D, Yoshihara K, Zheng S, Zhang W, Zou L, Abel T, Sadeghi S, Cohen ML, Eschbacher J, Hattab EM, Raghunathan A, Schniederjan MJ, Aziz D, Barnett G, Barrett W, Bigner DD, Boice L, Brewer C, Calatozzolo C, Campos B, Carlotti CG Jr, Chan TA, Cuppini L, Curley E, Cuzzubbo S, Devine K, DiMeco F, Duell R, Elder JB, Fehrenbach A, Finocchiaro G, Friedman W, Fulop J, Gardner J, Hermes B, Herold-Mende C, Jungk C, Kendler A, Lehman NL, Lipp E, Liu O, Mandt R, McGraw M, Mclendon R, McPherson C, Neder L, Nguyen P, Noss A, Nunziata R, Ostrom QT, Palmer C, Perin A, Pollo B, Potapov A, Potapova O, Rathmell WK, Rotin D, Scarpace L, Schilero C, Senecal K, Shimmel K, Shurkhay V, Sifri S, Singh R, Sloan AE, Smolenski K, Staugaitis SM, Steele R, Thorne L, Tirapelli DP, Unterberg A, Vallurupalli M, Wang Y, Warnick R, Williams F, Wolinsky Y, Bell S, Rosenberg M, Stewart C, Huang F, Grimsby JL, Radenbaugh AJ, Zhang J. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015 Jun 25;372(26):2481-2498. https://doi.org/10.1056/NEJMoa1402121

Close metadata